Welcome to our dedicated page for Can B news (Ticker: CANB), a resource for investors and traders seeking the latest updates and insights on Can B stock.
Canbiola, Inc. (OTCQB: CANB) is a prominent developer, manufacturer, and seller of a diverse range of cannabidiol (hemp) based products including oils, creams, moisturizers, chews, isolate, gel caps, and concentrates. The company has established its own line of proprietary products while also exploring synergistic opportunities through acquisitions within the CBD and medical cannabis industry. Hemp CBD, the non-psychoactive component devoid of THC, is utilized for pain relief, inflammation, and wellness programs. The company's wholly owned subsidiary, Pure Health Products, headquartered in Lacey, WA, serves as its primary development laboratory and production facility. Recently, Canbiola rolled out a durable medical device through its Duramed division, available via its doctor network to enhance patient treatment.
FAQ
What products does Canbiola, Inc. offer?
Where is Canbiola's prime development laboratory and production facility located?
What is the focus of Canbiola's Duramed division?
What is the legality status of hemp CBD products?